Literature DB >> 18321902

Automatic titration and calculation by predictive equations for the determination of therapeutic continuous positive airway pressure for obstructive sleep apnea.

Oreste Marrone1, Adriana Salvaggio, Salvatore Romano, Giuseppe Insalaco.   

Abstract

BACKGROUND: It is unknown to what extent therapeutic continuous positive airway pressure (CPAP) levels obtained by various methods for the treatment of obstructive sleep apnea syndrome (OSAS) differ. This study aimed to explore the relationships among pressures titrated by an automatic CPAP (APAP) device and those calculated using different predictive equations, and to compare different ranges of calculated pressures with pressure values titrated by APAP.
METHODS: In 140 OSAS patients, the 95th percentile pressure delivered by an APAP device (AutoSet T; ResMed; Sydney, NSW, Australia) during polysomnography, and pressures calculated by three equations (equation 1, Hoffstein and Miljetig [1994]; equation 2, Sériès et al [2000]; and equation 3, Stradling et al [2004]) were compared.
RESULTS: Titrated and calculated pressures were weakly correlated. Significant differences were found between the mean (+/- SD) pressures (11.1 +/- 1.6, 8.3 +/- 1.8, 10.5 +/- 1.6, and 10.3 +/- 1.3 cm H(2)O, respectively) for 95th percentile APAP, and pressures calculated by equations 1, 2, and 3, except between values calculated by equations 2and 3. Differences between the calculated and APAP-derived pressures were negative for the low calculated values, and were progressively attenuated, or became positive, for the high values. The differences were smallest for calculated pressures from 11 to > 13 cm H(2)O, which were represented to a greater extent among the values calculated by equations 2 and 3 than by those calculated by equation 1.
CONCLUSIONS: Considerably different therapeutic CPAP levels may be determined using various methods. The differences between the calculated and APAP-derived pressures are largest for calculated values of < 9 or > 15 cm H(2)O. The clinical consequences of these findings deserve further evaluation. Caution is still required before treating OSAS patients with calculated pressures.

Entities:  

Mesh:

Year:  2008        PMID: 18321902     DOI: 10.1378/chest.07-1372

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  6 in total

1.  Predictive equations for CPAP titration in OSAS patients.

Authors:  Donato Lacedonia; Roberto Sabato; Giovanna E Carpagnano; Pierluigi Carratù; Antonio Falcone; Felice Gadaleta; Onofrio Resta; Maria P Foschino Barbaro
Journal:  Sleep Breath       Date:  2011-01-06       Impact factor: 2.816

2.  Different Continuous Positive Airway Pressure Titration Modalities in Obstructive Sleep Apnea Syndrome Patients.

Authors:  Hadeer Ahmed Elshahaat; Tarek Abd El-Hakeem Mahfouz; Ashraf Elsyed Elshora; Amany Shaker
Journal:  Int J Gen Med       Date:  2021-12-21

3.  Agreement between 95th percentile pressure based on a 7-night auto-adjusting positive airway pressure trial vs. equation-based predictions in sleep apnea.

Authors:  Luis Torre-Bouscoulet; Armando Castorena-Maldonado; Elodia López-Escárcega; Juan Carlos Vázquez-García; Rogelio Pérez-Padilla
Journal:  J Clin Sleep Med       Date:  2009-08-15       Impact factor: 4.062

Review 4.  Mathematical Equations to Predict Positive Airway Pressures for Obstructive Sleep Apnea: A Systematic Review.

Authors:  Macario Camacho; Muhammad Riaz; Armin Tahoori; Victor Certal; Clete A Kushida
Journal:  Sleep Disord       Date:  2015-07-30

5.  Alternative Procedure to Individual Nasal Pressure Titration for Sleep Apnea.

Authors:  Ramon Farré; David Gozal; Josep M Montserrat
Journal:  J Clin Med       Date:  2021-04-01       Impact factor: 4.241

6.  Evaluation of a Decision Support System for Obstructive Sleep Apnea with Nonlinear Analysis of Respiratory Signals.

Authors:  Evangelos Kaimakamis; Venetia Tsara; Charalambos Bratsas; Lazaros Sichletidis; Charalambos Karvounis; Nikolaos Maglaveras
Journal:  PLoS One       Date:  2016-03-03       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.